Treatment of opportunistic mycoses: how long is long enough?

Groll, 1996, Trends in postmortem epidemiology of invasive fungal infections at a university hospital, J Infect, 33, 23, 10.1016/S0163-4453(96)92700-0 Singh, 2001, Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices, Clin Infect Dis, 33, 1692, 10.1086/323895 Kontoyiannis, 2002, Invasive aspergillosis in 2002: an update, Eur J Clin Microbiol Infect Dis, 21, 161, 10.1007/s10096-002-0699-z Lin, 2001, Aspergillosis casefatality rate: systematic review of the literature, Clin Infect Dis, 32, 358, 10.1086/318483 Beck-Sague, 1993, Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990, J Infect Dis, 167, 1247, 10.1093/infdis/167.5.1247 Marr, 2002, Epidemiology and outcome of mould infections in hematopoeitic stem cell transplant recipients, Clin Infect Dis, 34, 909, 10.1086/339202 Ribaud, 1999, Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation, Clin Infect Dis, 28, 322, 10.1086/515116 Denning, 1996, Therapeutic outcome in invasive aspergillosis, Clin Infect Dis, 23, 608, 10.1093/clinids/23.3.608 Herbrecht, 1999, Safety and efficacy of amphotericin B colloidal dispersion, Chemotherapy, 45, 67, 10.1159/000048472 Bowden, 2002, A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amhotericin B for treatment of invasive aspergillosis in immunocompromised patients, Clin Infect Dis, 35, 359, 10.1086/341401 Herbrecht, 2001, Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients, Eur J Clin Microbiol Infect Dis, 20, 77, 10.1007/s100960000437 Ng, 1995, Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections: evaluation of United Kingdom compassionate use data, Arch Intern Med, 155, 1093, 10.1001/archinte.1995.00430100129015 Mills, 1994, Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single centre experience of 133 episodes in 116 patients, Br J Haematol, 86, 754, 10.1111/j.1365-2141.1994.tb04825.x Jantunen, 2000, Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients, Bone Marrow Transplant, 26, 759, 10.1038/sj.bmt.1702604 Patterson, 2000, Invasive aspergillosis: disease spectrum, treatment practices, and outcomes, Medicine, 79, 250, 10.1097/00005792-200007000-00006 Ringden, 1991, Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invsive fungal infections in immunocompromised patients, J Antimicrob Chemother, 28, 73, 10.1093/jac/28.suppl_B.73 Herbrecht, 2002, Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis, N Engl J Med, 347, 408, 10.1056/NEJMoa020191 Denning, 2002, Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis, Clin Infect Dis, 34, 563, 10.1086/324620 Caillot, 2001, Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in paients with neutropenia, J Clin Oncol, 19, 253, 10.1200/JCO.2001.19.1.253 Caillot, 2001, Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS, Clin Infect Dis, 32, 83, 10.1086/323020 Kretschmar, 2001, Galactomannan enzyme immunoassay for monitoring sytemic infection with Aspergillus fumigatus in mice, Mycology, 41, 107 Offner, 1998, Impact of previous aspergillosis on the outcome of bone marrow transplantation, Clin Infect Dis, 26, 1098, 10.1086/520274 Saag, 2000, Practice guidelines for the management of cryptococcal disease, Clin Infect Dis, 30, 710, 10.1086/313757 Husain, 2001, Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome, Emerg Infect Dis, 7, 1, 10.3201/eid0703.017302 van der Horst, 1997, Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome, N Engl J Med, 337, 15, 10.1056/NEJM199707033370103 Singh N, Alexander B, Gupta KL. and and the Cryptococcus Collaborative Transplant Group. Characteristics and outcome of Cryptococcus neoformans infection of the central nervous system in organ transplant recipients: a prospective, multicenter study. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; San Diego, CA; September, 2002. Abstract M-885 Graybill, 2000, Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis, Clin Infect Dis, 30, 47, 10.1086/313603 Lortholary, 1999, Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timing, J Antimicrob Chemother, 43, 817, 10.1093/jac/43.6.817 Pappas, 2001, Cryptococcosis in human immunodeficiency virusnegative patients in the era of effective azole therapy, Clin Infect Dis, 33, 690, 10.1086/322597 Rose, 1978, Venous catheter-associated candidemia, Am J Med Sci, 275, 265, 10.1097/00000441-197805000-00004 Edwards, 1997, International conference for the development of a consensus on the management and prevention of severe candidal infections, Clin Infect Dis, 25, 43, 10.1086/514504 Rex, 2000, Practice guidelines for the treatment of candidiasis, Clin Infect Dis, 30, 662, 10.1086/313749 Anaissie, 1998, Predictors of adverse outcome in cancer patients with candidemia, Am J Med, 104, 238, 10.1016/S0002-9343(98)00030-8 Nguyen, 1996, The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance, Am J Med, 100, 617, 10.1016/S0002-9343(95)00010-0 Rex, 1994, Randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia, N Engl J Med, 331, 1325, 10.1056/NEJM199411173312001 Mora-Duarte, 2002, Comparison of caspofungin and amphotericin B for invasive candidiasis, N Engl J Med, 347, 2020, 10.1056/NEJMoa021585 Oude Lashof, 2003, Duration of antifungal treatment and development of delayed complications in patients with candidaemia, Eur J Clin Microbiol Infect Dis, 22, 43, 10.1007/s10096-002-0854-6 Fichtenbaum, 1999, A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B, Clin Infect Dis, 29, 1551, 10.1086/313499 Singh, 2001, Cytomegalovirus infection in liver transplant recipients: comparison of antigenemia and molecular biology assay, Liver Transplant, 7, 1004, 10.1053/jlts.2001.0071004 Mendez, 1998, Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation, Transplantation, 65, 1477, 10.1097/00007890-199806150-00012